Monoclonal Antibody in Treatment of Severe Allergic Asthma: A Meta-Analysis on The Effectiveness of Omalizumab

Authors

  • J.A. Kholmatov Teacher-assistant of the department of Pharmacology, Tashkent State Medical University, Uzbekistan
  • Das Sharodiya Student of International faculty, Tashkent State Medical University, Uzbekistan
  • R.Muhammad Zubair Teacher-assistant of the department of Clinic Pharmacology, Tashkent State Medical University, Uzbekistan
  • G.N.Avazova Teacher-assistant of the department of Clinic Pharmacology, Tashkent State Medical University, Uzbekistan

DOI:

https://doi.org/10.62480/tjms.2025.vol50.pp23-26

Keywords:

Asthma, Monoclonal Antibody, Omalizumab

Abstract

Asthma is a chronic obstructive pulmonary disease that has persistent symptoms with intermittent periods of exacerbation, representing the reduction in health status. Chronic obstructive pulmonary disease has become fourth leading cause of death in 2021, responsible for approximately 5% of total deaths[1,2,3,4]]. Frequent, recurring periods of exacerbation may reach significant severity, and advanced therapy may become necessary, including the prescription of omalizumab, the anti-IgE monoclonal antibody. This meta-analysis aims to determine and systematically review the effect of omalizumab compared with the placebo in the control of severe asthma

Downloads

Published

2025-11-20

Issue

Vol. 50 (2025): TJMS

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

User Rights

Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.

How to Cite

Monoclonal Antibody in Treatment of Severe Allergic Asthma: A Meta-Analysis on The Effectiveness of Omalizumab. (2025). Texas Journal of Medical Science, 50, 23-26. https://doi.org/10.62480/tjms.2025.vol50.pp23-26